UNSPSC 51282329: Erythromycin thiocyanate

This classification denotes a macrolide antibiotic C37H67NO13.CHNS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y7A95YRI88, chemically known as thiocyanic acid, compd. with erythromycin (1:1), but more generally known as erythromycin thiocyanate, which bears US NIH Compound Identifier 83938. Most nations, for tariff and trade purposes, schedule erythromycin thiocyanate under HS 29415000 and SITC 54139. As of Q4 2014, ERYTHROMYCIN THIOCYANATE remains US FDA's Preferred Term for this commodity.

SMILES: CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O.C(#N)S.

UNSPSC 51282329 Erythromycin thiocyanate, a Commodity code, nominally refers to a specific antibiotic compound, but recent state and local procurement activity under this code shows significant scope mismatch. The four recent opportunities tagged to this code procure naloxone and drug deactivation systems, direct-to-manufacturer pharmacy programs, medical and first aid supplies for emergency response, and multi-source generic pharmaceuticals and over-the-counter products through cooperative purchasing — none of which involve erythromycin thiocyanate. State and local issuing bodies using this code include county health agencies (Seminole County, Florida), state health and human services commissions (Texas HHS Commission), municipal fire and rescue divisions (City of Tampa Fire Department), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP). The mix reflects both direct local procurement and participation in regional or statewide cooperative agreements that serve multiple jurisdictions.

Geographic activity centers on Florida, Texas, and Minnesota, with the MMCAP cooperative extending to Oregon and other participating states. Representative recent opportunities include Seminole County's IFB 60459723LAS for naloxone and drug deactivation systems (1,900 and 800 units annually, respectively, due July 26, 2023); the Texas HHS Commission's RFI HHS0017013 for direct-to-manufacturer prescription program vendor capabilities (due April 3, 2026); the City of Tampa's IFB 26P00145 for medical and first aid supplies for the Fire Department Rescue Division (169 line items, estimated contract value $700,000, SLBE set-aside with 5% discount, due March 13, 2026); and MMCAP's RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products (proposals due March 26, 2026, effective July 1, 2026). The mismatch between the code's nominal scope and the actual work being solicited suggests either systematic tagging error in the source data or that erythromycin thiocyanate is one component within broader pharmaceutical and medical supply procurements that are mis-indexed at the commodity level.